Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy
详细信息    查看全文
文摘
| Figures/TablesFigures/Tables | ReferencesReferences

Purpose

Given the risk of undesired toxicity, prophylactic internal mammary (IM) chain irradiation should be offered only to patients at high risk of occult involvement. Lymphoscintigraphy for axillary sentinel node biopsy might help in selecting these patients.

Methods and Materials

We reviewed published studies with the following selection criteria: ?00 breast cancer patients referred for axilla sentinel node biopsy; scintigraphy performed after peritumoral or intratumoral tracer injection; IM biopsy in the case of IM drainage; and axilla staged routinely independent of IM status.

Results

Six prospective studies, for a total of 3,876 patients, fulfilled the inclusion criteria. Parasternal drainage was present in 792 patients (20.4 % ). IM biopsy was performed in 644 patients and was positive in 111 (17.2 % ). Of the positive IM biopsies, 40 % were associated with tumors in the lateral breast quadrants. A major difference in the IM positivity rate was found according to the axilla sentinel node status. In patients with negative axilla, the IM biopsy was positive in 7.8 % of cases. In patients with positive axilla, however, the IM biopsy was positive in 41 % (p < .00001). Because biopsy of multiple IM hot nodes is difficult, the true risk could be even greater, probably close to 50 % .

Conclusions

Patients with IM drainage on lymphoscintigraphy and a positive axilla sentinel node have a high risk of occult IM involvement. These women should be considered for IM radiotherapy.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700